Clinical Trial Update: A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial update for TH-302 in subjects with solid tumors and pancreatic cancer has completed enrollment with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Solid Tumor

Drugs mentioned

• TH-302 (evofosfamide)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Solid Tumor, Pancreatic Cancer | Phase 1 | Status: COMPLETED | Results posted: 2018-10-15